Stage-dependent BDNF serum concentrations in Alzheimer's disease

C Laske, E Stransky, T Leyhe, GW Eschweiler… - Journal of neural …, 2006 - Springer
Alzheimer's disease (AD) is characterized by cognitive decline and loss of neurons in
specific brain regions. Recent findings have suggested an involvement of brain-derived …

Behavioural and cellular effects of exogenous amyloid-β peptides in rodents

C Chambon, N Wegener, A Gravius… - Behavioural brain research, 2011 - Elsevier
A better understanding of Alzheimer's disease (AD) and the development of disease
modifying therapies are some of the biggest challenges of the 21st century. One of the core …

Nitric oxide mimetic molecules as therapeutic agents in Alzheimer's disease

GRJ Thatcher, BM Bennett… - Current Alzheimer …, 2005 - ingentaconnect.com
Nitric oxide is multifunctional messenger molecule in the brain, playing important roles
including in learning and memory and in regulating the expression of trophic factors that …

[HTML][HTML] Time-course and regional analyses of the physiopathological changes induced after cerebral injection of an amyloid β fragment in rats

C Zussy, A Brureau, B Delair, S Marchal… - The American journal of …, 2011 - Elsevier
Alzheimer's disease (AD) is a neurodegenerative pathology characterized by the presence
of senile plaques and neurofibrillary tangles, accompanied by synaptic and neuronal loss …

Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease

M Srivareerat, TT Tran, S Salim, AM Aleisa… - Neurobiology of …, 2011 - Elsevier
Alzheimer's disease (AD) is a devastating neurodegenerative disorder characterized by
increased deposition of beta-amyloid (Aβ) peptides and progressive cholinergic dysfunction …

Immunocytochemical evidence that amyloid β (1–42) impairs endogenous antioxidant systems in vivo

HC Kim, K Yamada, A Nitta, A Olariu, MH Tran… - Neuroscience, 2003 - Elsevier
Amyloid β, the major constituent of the senile plaques in the brains of patients with
Alzheimer's disease, is cytotoxic to neurons and has a central role in the pathogenesis of the …

β-Amyloid neurotoxicity is exacerbated during glycolysis inhibition and mitochondrial impairment in the rat hippocampus in vivo and in isolated nerve terminals …

C Arias, T Montiel, R Quiroz-Báez, L Massieu - Experimental neurology, 2002 - Elsevier
Senile plaques composed mainly by β-amyloid (Aβ) protein are one of the pathological
hallmarks of Alzheimer's disease (AD). In vitro, Aβ and its active fragment 25–35 have been …

Amyloid β-peptide induces cholinergic dysfunction and cognitive deficits: a minireview

MH Tran, K Yamada, T Nabeshima - Peptides, 2002 - Elsevier
Amyloid β-peptide (Aβ) plays a critical role in the development of Alzheimer's disease (AD).
Much progress has been made in understanding this age-related neurodegenerative …

Memory deficits and increased emotionality induced by β-amyloid (25–35) are correlated with the reduced acetylcholine release and altered phorbol dibutyrate …

A Olariu, MH Tran, K Yamada, M Mizuno… - Journal of Neural …, 2001 - Springer
In the present study we found that chronic infusion of β-amyloid fragment (25–35) at
nanomolar concentration into rat cerebral ventricle impairs learning and memory. At a …

Treatment with the neurotoxic Aβ (25–35) peptide modulates the expression of neuroprotective factors Pin1, Sirtuin 1, and brain-derived neurotrophic factor in SH …

F Lattanzio, L Carboni, D Carretta, S Candeletti… - Experimental and …, 2016 - Elsevier
The deposition of Amyloid β peptide plaques is a pathological hallmark of Alzheimer's
disease (AD). The Aβ (25–35) peptide is regarded as the toxic fragment of full-length Aβ (1 …